Evidence map›Paper›PMID 35115399›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Mechanism of Bloom syndrome complex assembly required for double Holliday junction dissolution and genome stability.

Charlotte Hodson, Jason K K Low, Sylvie van Twest, Samuel E Jones, Paolo Swuec, Vincent Murphy, Kaima Tsukada, Matthew Fawkes, Rohan Bythell-Douglas, Adelina Davies and 9 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Generation of double Holliday junction DNAs and their dissolution/resolution within a chromatin context.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Charlotte HodsonGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Jason K K LowSchool of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0003-0862-0012
Sylvie van TwestGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.ORCID 0000-0001-5602-0906
Samuel E JonesDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom.ORCID 0000-0002-1177-2810
Paolo SwuecFrancis Crick Institute, London NW1 1AT, United Kingdom.
Vincent MurphyGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.ORCID 0000-0003-2791-303X
Kaima TsukadaDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom.ORCID 0000-0002-6725-9514
Matthew FawkesDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom.
Rohan Bythell-DouglasGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Adelina DaviesFrancis Crick Institute, London NW1 1AT, United Kingdom.
Jessica K HolienDepartment of Medicine (St. Vincent's), University of Melbourne, Fitzroy, VIC 3065, Australia.
Julienne J O'RourkeGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Benjamin L ParkerSchool of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.
Astrid GlaserGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
Michael W ParkerStructural Biology Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.ORCID 0000-0002-3101-1138
Joel P MackaySchool of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0001-7508-8033
Andrew N BlackfordDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom.ORCID 0000-0003-1979-021X
Alessandro CostaFrancis Crick Institute, London NW1 1AT, United Kingdom.ORCID 0000-0003-1126-2498
Andrew J DeansGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia; adeans@svi.edu.au.ORCID 0000-0002-5271-4422
St Vincents Institute of Medical Research · AUThe University of Melbourne · AUJohn Radcliffe Hospital · GBThe Francis Crick Institute · GBThe University of Sydney · AUTokyo Institute of Technology · JP

Funding

Cancer Research UK 15852Cancer Research UK 20772Cancer Research UK C29215/A20772Wellcome Trust
6 · The paper itself

Abstract

The RecQ-like helicase BLM cooperates with topoisomerase IIIα, RMI1, and RMI2 in a heterotetrameric complex (the "Bloom syndrome complex") for dissolution of double Holliday junctions, key intermediates in homologous recombination. Mutations in any component of the Bloom syndrome complex can cause genome instability and a highly cancer-prone disorder called Bloom syndrome. Some heterozygous carriers are also predisposed to breast cancer. To understand how the activities of BLM helicase and topoisomerase IIIα are coupled, we purified the active four-subunit complex. Chemical cross-linking and mass spectrometry revealed a unique architecture that links the helicase and topoisomerase domains. Using biochemical experiments, we demonstrated dimerization mediated by the N terminus of BLM with a 2:2:2:2 stoichiometry within the Bloom syndrome complex. We identified mutations that independently abrogate dimerization or association of BLM with RMI1, and we show that both are dysfunctional for dissolution using in vitro assays and cause genome instability and synthetic lethal interactions with GEN1/MUS81 in cells. Truncated BLM can also inhibit the activity of full-length BLM in mixed dimers, suggesting a putative mechanism of dominant-negative action in carriers of BLM truncation alleles. Our results identify critical molecular determinants of Bloom syndrome complex assembly required for double Holliday junction dissolution and maintenance of genome stability.

Indexed as

AllelesBloom SyndromeCarrier ProteinsCell LineDNA, CruciformDNA Topoisomerases, Type IGenomic InstabilityHumansMutationProtein BindingRecombination, GeneticRecQ HelicasesSolubilityCarrier ProteinsDNA, CruciformDNA Topoisomerases, Type IRecQ HelicasesBloom’s complexcross-link mass spectrometrygenome stabilityhelicasetopoisomerase

Identifiers

PMID35115399
PMCPMC8832983
OpenAlexW4210320704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.